APA (7th ed.) Citation

A, D., M, J., M, F., & RJ, E. (2025). Engineered pluronic nanomicelles containing ATRA and sodium butyrate for selective TNBC differentiation therapy. Medical oncology (Northwood, London, England), 43(2), 92. https://doi.org/10.1007/s12032-025-03206-1

Chicago Style (17th ed.) Citation

A, Doustmihan, Jaymand M, Fathi M, and Esfahlan RJ. "Engineered Pluronic Nanomicelles Containing ATRA and Sodium Butyrate for Selective TNBC Differentiation Therapy." Medical Oncology (Northwood, London, England) 43, no. 2 (2025): 92. https://doi.org/10.1007/s12032-025-03206-1.

MLA (9th ed.) Citation

A, Doustmihan, et al. "Engineered Pluronic Nanomicelles Containing ATRA and Sodium Butyrate for Selective TNBC Differentiation Therapy." Medical Oncology (Northwood, London, England), vol. 43, no. 2, 2025, p. 92, https://doi.org/10.1007/s12032-025-03206-1.